"Get quality, comprehensive heart and vascular care at North Central Heart."

During the past decade, North Central Heart Institute conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 14 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Central Heart Institute" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Medtronic Cardiovascular" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Endologix" with 2 trials sponsored and "Philips Clinical & Medical Affairs Global" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Central Heart Institute" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Cordis Corporation" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "North Central Heart Institute" are "Aortic Aneurysm, Abdominal" (3 trials), "Carotid Stenosis" (3 trials), "Peripheral Arterial Disease" (3 trials), "Carotid Artery Stenosis" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "North Central Heart Institute" in a lesser frequency.

Most popular intervention types in "North Central Heart Institute" are "Device" (22 trials), "Procedure" (4 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AFX EVAR AAA Graft System" (1 trials), "AMPLATZER PFO Occluder" (1 trials), "AneuRx AAA stent graft / Talent AAA stent graft" (1 trials), "Apixaban" (1 trials) and "BARD LifeStent" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Central Heart Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "North Central Heart Institute". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in North Central Heart Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in North Central Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".